Addressing the dual challenge of treatment access and innovation in anxiety disorders
BMJ · 16.04.2026 · 393 · s673
DOI: 10.1136/bmj.s673 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, online erschienen am 16.04.2026. Verfasst von Judith M Laposa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Judith.Laposa@camh.ca. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Improved access, therapist training, and ongoing innovation are necessary pillars for effective clinical care
Autor:innen und Institutionen
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Judith.Laposa@camh.ca.
- Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
- Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Zitieren
APA
Laposa, J. M., Rowa, K., Soreni, N., & Zai, G. (2026). Addressing the dual challenge of treatment access and innovation in anxiety disorders. BMJ, 393, s673. https://doi.org/10.1136/bmj.s673
Vancouver
Laposa JM, Rowa K, Soreni N, Zai G. Addressing the dual challenge of treatment access and innovation in anxiety disorders. BMJ. 2026;393:s673. doi:10.1136/bmj.s673
BibTeX
@article{Laposa2026,
author = {Laposa, Judith M and Rowa, Karen and Soreni, Noam and Zai, Gwyneth},
title = {Addressing the dual challenge of treatment access and innovation in anxiety disorders},
journal = {BMJ},
year = {2026},
volume = {393},
pages = {s673},
doi = {10.1136/bmj.s673}
}
EUVIMED